Related Experiment Video
Updated: Jul 27, 2026
06:54
Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions
Published on: June 21, 2019
Obesity, hypertension, and the heart
V Thakur1, R Richards, E Reisin
1Section of Nephrology, Louisiana State University School of Medicine, New Orleans, USA.
The American Journal of the Medical Sciences
|April 20, 2001
Summary
Obesity hypertension is common, linked to metabolic and endocrine factors. Weight loss effectively reduces blood pressure by addressing these mechanisms, though specific drug recommendations are lacking.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Syndrome
Background:
- Hypertension is significantly more prevalent in obese individuals compared to lean individuals across all age groups.
- Obesity-induced hypertension is associated with multiple endocrine, genetic, and metabolic factors, including insulin resistance, hyperinsulinemia, elevated aldosterone, and salt sensitivity.
Purpose of the Study:
- To explore the pathophysiological mechanisms linking obesity and hypertension.
- To evaluate the impact of weight loss on obesity-hypertension.
- To discuss the current state of pharmacotherapy for obesity-hypertension.
Main Methods:
- Review of existing literature on the mechanisms of obesity-hypertension.
- Analysis of the effects of weight loss on blood pressure and associated pathophysiological factors.
- Discussion of the challenges and considerations in pharmacologic treatment strategies.
Main Results:
- Obesity hypertension involves pressure and volume overload, leading to left ventricular hypertrophy and increased risk of heart failure.
- Weight loss, even modest, demonstrates efficacy in reducing obesity-hypertension by potentially improving underlying mechanisms.
- No definitive pharmacotherapeutic recommendations exist due to the varied efficacy and side effect profiles of different drug classes.
Conclusions:
- Obesity hypertension is a complex condition driven by multiple interrelated factors.
- Weight reduction is a key therapeutic strategy for managing obesity-hypertension.
- Further research is needed to establish optimal pharmacologic treatments for this patient population.
Related Concept Videos
01:18Disorders of the Autonomic Nervous System
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Raynaud's disease, also known as Raynaud's phenomenon, is a...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...